Compare Nokia Corp (NOK) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nokia Corp vs Regeneron Pharmaceuticals Inc — how do they compare? Nokia Corp trades at $11 (market cap $56.70B), while Regeneron Pharmaceuticals Inc trades at $673.67 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and Nokia Corp pays the higher dividend (1.63%). Which is the better fit depends on your goals.
| NOK | REGN | |
|---|---|---|
Market Cap | $56.70B | $70.47B |
Sector | Technology | Health |
52-Week High | $16.83 | $812.27 |
52-Week Low | $4.05 | $545.46 |
Enterprise Value | $53.51B | $64.42B |
Dividend Yield | 1.63% | 0.56% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
